Hematologist
CION Cancer Clinics
How myeloma treatment costs change across every line | CION Cancer Clinics
Myeloma treatment in India usually costs least in the first line and more with each later line, because later lines rely on newer, patented medicines. A transplant, if it suits you, adds a large one-time cost, and maintenance tablets can run for years. Tests, bone care and travel add more. Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance can change what your family pays. At CION Cancer Clinics, our haematology team supports patients and families through treatment, cost questions and life at home.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Why does myeloma cost change from one line to the next?
- What drives the cost at each stage?
- What do the words on the estimate mean?
- Which costs do families forget to count?
- How much can schemes and insurance take off?
- What tends to raise or lower the bill?
- What do families believe about myeloma cost that is not true?
- Common questions about myeloma treatment cost
The short answer
Why does myeloma cost change from one line to the next?
Myeloma treatment is usually given in lines, and each line tends to cost more than the one before. The first line often uses medicines with generic versions. Later lines more often use newer, patented medicines, which cost much more each month.
What a "line" means
A line of treatment is one plan of medicines, given until it stops working or causes too many problems. Myeloma is a cancer of plasma cells, a type of cell in the bone marrow. For most people it is kept under control for long periods rather than removed, and it tends to come back. When it does, a new line starts. So the real cost is spread over several years, not paid in one go.
Why the total is hard to predict
Nobody can tell you at diagnosis how many lines you will need or how long each one will last. Some people stay on the first line and its maintenance medicine for a long time. Others move through lines more quickly. Your age, your kidneys, your general fitness and the features of the myeloma itself all shape the plan, and therefore the bill.
This page describes typical patterns only. Your own plan, and its cost, comes from your haematologist.Line by line
What drives the cost at each stage?
-
First line: induction
Induction means the first treatment to bring the myeloma under control. It is often a combination such as bortezomib, lenalidomide and dexamethasone, given in day-care and as tablets. Generic versions of these exist, which helps. Adding daratumumab, an antibody drip, can raise the cost sharply.
-
Autologous stem cell transplant, if suitable
For fitter patients, a transplant using your own stem cells may follow. It is a large one-time cost for the hospital stay, cell collection and support. CION's team assesses whether it suits you and coordinates it with a qualified transplant centre.
-
Maintenance
A lower-intensity medicine, often lenalidomide tablets, is taken to keep the myeloma quiet. It is a smaller monthly bill, but it can run for years, so it adds up.
-
Second line, when the myeloma returns
The plan changes to medicines the myeloma has not seen, such as carfilzomib, pomalidomide or daratumumab. Several are still costly, and combinations multiply that cost.
-
Later lines
Newer options include CAR-T cell therapy and bispecific antibodies. These are among the costliest treatments in medicine, are given only at a few qualified centres, and do not suit everyone.
On your estimate
What do the words on the estimate mean?
- Relapsed
- The myeloma was under control and has come back. This usually starts a new line of treatment.
- Refractory
- The myeloma did not respond to a medicine, or grew while you were taking it. It points your team towards a different group of medicines.
- Cycle
- One round of treatment followed by a planned gap. Estimates are often quoted per cycle, so ask how many cycles the plan expects.
- Day-care
- Treatment given in the hospital without an overnight stay. It carries its own bed and nursing charges on top of the medicine.
- Supportive care
- Everything that protects you during treatment: bone-strengthening drips, medicines to prevent infection, and blood tests.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Outside the medicines
Which costs do families forget to count?
Myeloma affects the bones, the kidneys and the body's defences. Each of those brings its own bills.
Tests to track the myeloma
Blood and urine tests that measure the myeloma protein are repeated regularly. A bone marrow test and scans are needed at diagnosis and at key points later.
Usually includes
- Serum free light chains and protein tests
- Bone marrow biopsy
- PET-CT or MRI scans
Bone care
Many people receive a regular bone-strengthening drip. Some need radiotherapy or a procedure for a painful or broken bone, and dental checks before starting.
Infections and kidneys
Treatment lowers your defences, so vaccines, preventive medicines and sometimes a hospital stay for infection add up. If the kidneys are affected, there may be extra tests or dialysis.
Travel and time off
Day-care visits can be frequent in the first line. For a family from a district, travel, a place to stay and lost wages can be a large share of the real cost.
Schemes and insurance
How much can schemes and insurance take off?
Often a lot for the first line, and less for newer later-line medicines. What you pay yourself depends on which packages your scheme lists and what your policy covers.
Government schemes
Aarogyasri and PM-JAY pay for listed treatment packages at empanelled hospitals, and myeloma care is generally included. Newer medicines may sit outside those packages, or need special approval. CGHS, ECHS and EHS have their own rules for medicines and transplant. Scheme entitlements change, so check the current rules with the scheme desk before each new line.
Private insurance
Most cashless policies pay for day-care drips and hospital stays. Tablets such as lenalidomide or pomalidomide taken at home may not be covered unless the policy has an outpatient or oral medicine clause. Watch the family sum insured: a transplant or a costly later line can use most of it.
What this page cannot tell you
It cannot give you a quote or say how many lines you will need. It also cannot tell you how well any line will work for you. Your haematologist is the person to ask about your own outlook.
There is no EMI offer at CION. Ask for a written, line-by-line estimate instead.Side by side
What tends to raise or lower the bill?
Tends to raise it
Tends to lower it
Patented medicines with no generic version
Generic versions your haematologist is comfortable with
Antibody drips added to a combination
Tablet-based plans, where they suit you
Hospital stays for infection or kidney problems
Vaccines and preventive care taken on time
Frequent travel from a district
Routine blood tests done nearer home under shared care
Commonly believed
What do families believe about myeloma cost that is not true?
"We should keep the money for later, and choose a cheaper first line."
The first line is often your longest period of control, so it matters a great deal. Talk openly about money with your haematologist. They can often build a plan that fits your budget without giving up what matters most.
"The newest medicine is always the right one."
A newer medicine is not automatically better for you. The choice depends on what you have already had, your kidneys, your fitness and the features of the myeloma. Price alone tells you nothing about fit.
"Once the protein level is normal, maintenance tablets are a waste."
Maintenance is given to keep the myeloma quiet after it has come under control. Stopping it on your own to save money can let it return sooner. Any change should come from your haematologist.
"A transplant means we will not need to pay again."
A transplant usually lengthens the period of control, but myeloma tends to come back. Most families should expect maintenance and follow-up costs afterwards, and plan for them.
Questions we are asked
Common questions about myeloma treatment cost
Which line of myeloma treatment costs the most?
Later lines usually cost the most each month, because they rely more on newer, patented medicines and combinations. CAR-T cell therapy and bispecific antibodies sit at the top. A transplant is a large one-time cost. The first line can also be costly if an antibody drip such as daratumumab is added.
Does Aarogyasri cover myeloma treatment?
Myeloma care is generally included in Aarogyasri and PM-JAY packages at empanelled hospitals. Newer medicines and some later-line treatments may not be listed, or may need special approval. Take your card and reports to the scheme desk, and check again before each new line, because the rules change.
Does CION do the stem cell transplant itself?
CION's haematology team assesses whether a transplant suits you, discusses your case at a tumour board and coordinates the transplant with a qualified centre. Ask that centre for a written package estimate, and ask what is excluded, such as extra days, blood support or medicines after discharge.
Are generic myeloma medicines as good as branded ones?
Generic medicines sold legally in India must meet the regulator's quality rules, and many people take generic bortezomib or lenalidomide. Ask your haematologist which versions they are comfortable using, and avoid switching makers often without telling your team.
How long will maintenance tablets need to be bought?
Maintenance often continues for a long time, sometimes years, as long as it keeps the myeloma quiet and you manage the side effects. Your haematologist decides when it should change or stop. Budget for it as a long-running monthly cost, and ask whether your scheme or policy covers home tablets.
Is CAR-T available for myeloma in India, and who can get it?
CAR-T is offered at a small number of qualified centres, and it is usually considered only after several earlier lines. It does not suit everyone, and it is very costly. If your team thinks it may be an option, ask them which centres to approach and what the full process involves.
Can we pause treatment when money runs short?
Please do not pause or skip treatment on your own. Tell your haematologist that cost is the problem. There may be a generic, a tablet-based option, a scheme route or an access programme that helps. A plan changed by your team is far safer than one stopped without warning.
What should we ask for before a new line starts?
Ask for a written estimate per cycle, and how many cycles are planned. Ask which medicines are generic, which parts are day-care and which are home tablets. Ask what supportive care and tests are expected, and whether your scheme or insurer has confirmed cover.
What moves the figure
What affects the cost
Four things change the total more than anything else.
The technique used
A shaped or image-guided delivery costs more than a conventional one, and is chosen on clinical grounds rather than preference.
How many sessions
The total is driven by the number of sittings or cycles, not by a single per-visit figure.
Supporting tests
Scans, blood work and pathology done alongside treatment are billed separately.
Your cover
Aarogyasri, CGHS, ECHS, EHS or cashless insurance usually change the out-of-pocket figure substantially.
Paying for it
Insurance, schemes and payment
What you actually pay usually differs a great deal from the sticker figure.
AarogyasriEmpanelled. Bring the card and a referral where you have one.
CGHS / ECHS / EHSAccepted at CION centres for eligible treatment.
Cashless insuranceMost major insurers are empanelled. Pre-authorisation is handled by our desk.
Self-payItemised estimate given before treatment starts. No EMI scheme exists.
Accreditation and empanelment
- NABH
- NABL
- ISO 9001:2015
- ArogyaSri empanelled
- CGHS accepted
- ECHS accepted
- EHS accepted
- Major cashless insurers
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. A haematology consultation can be booked at any of these centres through one helpline, and your team will tell you where each test or treatment takes place.
Warangal
Vizag
Sources
- National Cancer Institute — Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ), Patient Version
- Cancer Research UK — Myeloma
- Leukemia & Lymphoma Society — Myeloma
- National Health Authority — Ayushman Bharat PM-JAY
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Bone Marrow Transplant Cost in India: Full BreakdownWhere the transplant money goesTransplant Under Aarogyasri and NTR Vaidya SevaHow the state schemes treat a transplantGovernment Support for Blood Cancer in TelanganaWhich schemes may cover myeloma careBlood cancer guideMyeloma and other blood cancers explainedCost, Schemes and Access in IndiaEvery cost and scheme guide in one place
Talk to us
Have a myeloma estimate you want to understand?
Share your reports and your scheme or insurance details. Our haematology team will explain the likely plan and what to ask before each new line.